| abstract |
FIELD: medicine. n SUBSTANCE: group of inventions relates to method for preventing or treating recurrent middle ear acute otitis, arising as result of Streptococcus pneumoniae infection in patients risk group, involving administering therapeutically effective amount of composition, at least once, to patient. Added composition contains at least one immunogenic polypeptide chosen from group consisting of polypeptides S. pneumoniae PhtD, PhtE, PcpA, LytB and deactivated pneumolysin. n EFFECT: declared group of inventions has effective protective action. n 37 cl, 6 dwg, 3 tbl, 3 ex |